CAS 2761259-22-5

9H-Purine-2,6-diamine, N6-[4-[(4-aminobutyl)amino]phenyl]-N2-(trans-4-aminocyclohexyl)-9-cyclopentyl-

Description:

9H-Purine-2,6-diamine, N6-[4-[(4-aminobutyl)amino]phenyl]-N2-(trans-4-aminocyclohexyl)-9-cyclopentyl- is a complex organic compound characterized by its purine base structure, which is a fundamental component of nucleic acids. This substance features multiple functional groups, including amine and cyclopentyl moieties, contributing to its potential biological activity. The presence of the aminobutyl and cyclohexyl groups suggests that it may interact with various biological targets, possibly influencing cellular processes or signaling pathways. The compound's molecular structure indicates that it may exhibit properties such as solubility in organic solvents and potential reactivity with electrophiles or nucleophiles. Its specific applications could range from research in biochemistry to potential therapeutic uses, although detailed studies would be necessary to elucidate its pharmacological profile and safety. As with many synthetic compounds, understanding its stability, reactivity, and interactions in biological systems is crucial for determining its utility in scientific and medical contexts.

Formula: C₂₆H₃₉N₉

Synonyms:

• 9H-Purine-2,6-diamine, N6-[4-[(4-aminobutyl)amino]phenyl]-N2-(trans-4-aminocyclohexyl)-9-cyclopentyl-
• PDGFRα/FLT3-ITD-IN-3

PDGFRα/FLT3-ITD-IN-3

CAS: 2761259-22-5

PDGFRα/FLT3-ITD-IN-3 (Compound 18d) is a potent inhibitor of PDGFRα (IC50: 0.153 μM), FLT3 (IC50: 0.004 μM) and PDGFRα/FLT3-ITD-IN-3 has the potential to be

Formula: C₂₆H₃₉N₉

Color and Shape: Solid

Molecular weight: 477.65

Ref: TM-T63127